Health can’t wait; tell Congress to support the Treat and Reduce Obesity Act today!

Today, Medicare is prohibited from covering FDA-approved anti-obesity medications, leaving millions of older Americans without access to safe, effective treatments. 

Despite obesity being a leading driver of chronic disease and health costs, only 1% of eligible patients currently receive these medications.

The Treat and Reduce Obesity Act (TROA) (S.1973/H.R. 4231) would close this gap by:

• Allowing Medicare to cover FDA-approved anti-obesity medications.
• Expanding access to providers and evidence-based programs that prevent and treat obesity. 
   

Obesity costs the U.S. healthcare system nearly $173 billion annually, much of which falls on Medicare and Medicaid. Research shows that expanded coverage could save Medicare nearly $175 billion in the first 10 years alone, while helping patients live healthier, longer lives.

Please note: All personalized or modified messages are subject to review by our team. We encourage you to keep your message respectful and professional to help ensure it’s delivered successfully.